Physician
Pathology
Dr. Sarah M. Drawz, MD
|
|
Give Review
Sarah M. Drawz, MD is an expert in the field of Pathology. Sarah M. Drawz is a published doctor. He has 19 papers published. The most current publication "Morphometric measurement of submucosal thickness in areas of fat deposition in the terminal ileum and colonic sections, with correlation with body mass index, weight a..."
Publications
- Morphometric measurement of submucosal thickness in areas of fat deposition in the terminal ileum and colonic sections, with correlation with body mass index, weight a...
- Observational study of corrected count increments after transfusion of platelets treated with riboflavin pathogen reduction technology in additive solutions.
- New β-lactamase inhibitors: A therapeutic renaissance in an "MDR world"!
- Pokes, pathogens, and primum non nocere: prudent prophylaxis protocols for prostate biopsy.
- Susceptibility to Alternative Oral Antimicrobial Agents in Relation to Sequence Type ST131 Status and Co-resistance Phenotype Among Recent Escherichia coli Isolates fr...
- Inactivation of a class A and a class C β-lactamase by 6β-(hydroxymethyl)penicillanic acid sulfone.
- Resistance Emergence Mechanism and Mechanism of Resistance Suppression by Tobramycin for Cefepime for Pseudomonas aeruginosa.
- Exploring sequence requirements for C(3) /C(4) carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC Î&sup...
- Modifications of the C6-substituent of penicillin sulfones with the goal of improving inhibitor recognition and efficacy.
- Novel insights into the mode of inhibition of class A SHV-1 beta-lactamases revealed by boronic acid transition state inhibitors.
- Design, synthesis, and crystal structures of 6-alkylidene-2'-substituted penicillanic acid sulfones as potent inhibitors of Acinetobacter baumannii OXA-24 carbapenemase.
- Penicillin sulfone inhibitors of class D beta-lactamases.
- Enhancing resistance to cephalosporins in class C beta-lactamases: impact of Gly214Glu in CMY-2.
- Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design.
- Three decades of beta-lactamase inhibitors.
- The role of a second-shell residue in modifying substrate and inhibitor interactions in the SHV beta-lactamase: a study of ambler position Asn276.
- DNA dissociation and degradation at gold nanoparticle surfaces.
- Novel β-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistance.
Schools
Case Western Reserve University School of Medicine
Doctors Specialties
- Pathology
Accepted Insurances
Education
-
University of Minnesota
Helpful Reviews
Similar Doctors
|
|
Dr. Katharine S. Park, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Theresa A. Steeper, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robin K. Solomon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael W. Steffes, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jaena J. Wisniewski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary T. Copland, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shifteh Vahidi, MD |
|
|
Dr. Alesia Kaplan, MD
This Doctor is OpenDoctor Recommended.
|